Holen Sie sich die Stockscreener-App
3.07
1.29%
-0.04
Schlusskurs vom Vortag:
$3.11
Offen:
$3.11
24-Stunden-Volumen:
689.83K
Relative Volume:
0.73
Marktkapitalisierung:
$530.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.70M
KGV:
-9.303
EPS:
-0.33
Netto-Cashflow:
$-51.36M
1W Leistung:
+7.34%
1M Leistung:
+4.78%
6M Leistung:
+3.02%
1J Leistung:
-34.96%
1-Tages-Spanne:
$3.07
$3.20
1-Wochen-Bereich:
$2.77
$3.20
52-Wochen-Spanne:
$2.31
$5.11
Savara Inc Stock (SVRA) Company Profile
Firmenname
Savara Inc
Sektor
Branche
Telefon
51285113796
Adresse
6836 BEE CAVE ROAD, AUSTIN, TX
Vergleichen Sie SVRA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SVRA
Savara Inc
|
3.07 | 493.73M | 0 | -54.70M | -51.36M | -0.33 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Savara Inc Stock (SVRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-11-13 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2024-02-15 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-11-07 | Eingeleitet | Guggenheim | Buy |
| 2023-05-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-03-31 | Herabstufung | Jefferies | Buy → Hold |
| 2021-03-16 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-15 | Eingeleitet | Oppenheimer | Outperform |
| 2019-06-13 | Bestätigt | H.C. Wainwright | Buy |
| 2019-06-13 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-13 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2018-08-13 | Fortgesetzt | ROTH Capital | Neutral |
| 2018-01-03 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-09-27 | Fortgesetzt | ROTH Capital | Buy |
| 2017-09-22 | Eingeleitet | Jefferies | Buy |
| 2017-09-11 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Savara Inc Aktie (SVRA) Neueste Nachrichten
HC Wainwright Has Positive Forecast for Savara Q2 Earnings - Defense World
Savara (SVRA) Price Target Lowered as Molbreevi Priority Review Anticipated | SVRA Stock News - GuruFocus
Savara (SVRA) Prepares for U.S. Launch Following BLA Submission - GuruFocus
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update | SVRA Stock News - GuruFocus
Savara Reports First Quarter 2025 Financial Results and Provides a Business Update - Business Wire
Autoimmune Pulmonary Alveolar Proteinosis Market to Expand Significantly by 2032, States DelveInsight Report | Savara Inc. - Barchart.com
Hsbc Holdings PLC Invests $48,000 in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Announces Participation in the H.C. Wainwright & Co. 3rd Annual BioConnect Investor Conference - Stock Titan
Savara Inc.'s (NASDAQ:SVRA) recent 16% pullback adds to one-year year losses, institutional owners may take drastic measures - simplywall.st
Wells Fargo & Company MN Has $182,000 Holdings in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Sold by MetLife Investment Management LLC - Defense World
Analysts Set Savara Inc (NASDAQ:SVRA) Target Price at $8.83 - Defense World
Barclays PLC Grows Stake in Savara Inc (NASDAQ:SVRA) - Defense World
Metric Deep Dive: Understanding Savara Inc (SVRA) Through its Ratios - DWinneX
Raymond James Financial Inc. Buys Shares of 259,798 Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
A stock that deserves closer examination: Savara Inc (SVRA) - uspostnews.com
Savara Announces Participation in the Upcoming Citizens Life Sciences Conference - Business Wire
Legal & General Group Plc Sells 12,613 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
Savara, Inc. to Host Earnings Call - ACCESS Newswire
Savara Inc (NASDAQ:SVRA) Shares Purchased by Geode Capital Management LLC - Defense World
JMP maintains $10 target on Savara stock post-BLA submission By Investing.com - Investing.com Nigeria
Examining Savara Inc (SVRA) more closely is necessary - uspostnews.com
JMP maintains $10 target on Savara stock post-BLA submission - Investing.com
Savara: Make-It-Or-Break-It Molbreevi BLA Filing (NASDAQ:SVRA) - Seeking Alpha
Savara Inc. Announces Equity Awards for New Employees - MSN
JPMorgan Chase & Co. Grows Stock Position in Savara Inc (NASDAQ:SVRA) - Defense World
Savara Inc (NASDAQ:SVRA) Shares Purchased by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Sells 4,330 Shares of Savara Inc (NASDAQ:SVRA) - Defense World
KLP Kapitalforvaltning AS Purchases Shares of 13,200 Savara Inc (NASDAQ:SVRA) - Defense World
Savara Announces New Employment Inducement Grant | SVRA Stock Ne - GuruFocus
Savara Announces New Employment Inducement Grant - Enidnews.com
Savara's Bold Move: 190K Share Grant Signals Aggressive Growth Strategy - Stock Titan
Savara Inc (NASDAQ:SVRA) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Savara Inc. Launches Convenient DBS Test for Diagnosing Rare Lung Disease - MSN
Savara to present aPAP treatment study at medical congresses By Investing.com - Investing.com Canada
Savara to present aPAP treatment study at medical congresses - Investing.com
Savara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcoming Scientific Conferences - MarketScreener
Breakthrough Phase 3 Results: New Treatment Could Transform Rare Lung Disease Management - Stock Titan
259,798 Shares in Savara Inc (NASDAQ:SVRA) Bought by Raymond James Financial Inc. - Defense World
Raymond James Financial Inc. Invests $798,000 in Savara Inc (NASDAQ:SVRA) - The AM Reporter
Savara Completes BLA Submission for MOLBREEVI to Treat aPAP - MSN
Health Check: How Prudently Does Savara (NASDAQ:SVRA) Use Debt? - simplywall.st
Savara Reports 2024 Financial Results and Provides Updates on MOLBREEVI Progress - MSN
Savara Secures $200 Million Loan Agreement with Hercules Capital - MSN
Finanzdaten der Savara Inc-Aktie (SVRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.54%
7.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):